Tomosynthesis Market Research Report By Application Type (Breast Cancer, Lung Cancer, Osteoporosis, Corneal Disease, Kidney Stone), By End-Use Setting (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Research Institutions), By Technology (Digital Tomosynthesis, Digital Breast Tomosynthesis), By Component (X-ray Tube, Detector, Image Processing Software, Accessories and Consumables) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2032

Tomosynthesis Market Overview

As per MRFR analysis, the Tomosynthesis Market Size was estimated at 5.78 (USD Billion) in 2022. The Tomosynthesis Market Industry is expected to grow from 6.38(USD Billion) in 2023 to 15.5 (USD Billion) by 2032. The Tomosynthesis Market CAGR (growth rate) is expected to be around 10.37% during the forecast period (2024 - 2032).

Key Tomosynthesis Market Trends Highlighted

The Tomosynthesis Market addresses the increasing demand for healthcare and its supporting technologies due to its ability to improve the diagnostic process. As demand for healthcare rises across the globe, the market for tomosynthesis expands. The developments in image analysis and reconstruction techniques have also facilitated the adoption of tomosynthesis.

There is a noticeable long-term trend in the tomosynthesis market in which artificial intelligence is being used for automated image analysis and interpretation. The market has other trends, which include creating 3D tomosynthesis systems and trying tomosynthesis for surgery. The market has opportunities, which include applying tomosynthesis in a newly developing region, extending radiation therapy application and enhancing imaging with tomosynthesis in combination with other imaging techniques.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Tomosynthesis Market Drivers

Increasing Adoption of Tomosynthesis in Breast Cancer Screening

Tomosynthesis, also known as digital breast tomosynthesis (DBT), is a medical imaging technique that uses low-dose X-rays to create three-dimensional (3D) images of the breast. It is increasingly being adopted as a screening tool for breast cancer, as it has been shown to be more sensitive and specific than traditional two-dimensional (2D) mammography. In 2021, the American Cancer Society (ACS) updated its breast cancer screening guidelines to include tomosynthesis as an option for women at average risk of breast cancer.This is a significant development, as the ACS is one of the most influential organizations in the field of cancer prevention and control. The ACS's endorsement of tomosynthesis is likely to lead to increased adoption of the technology in the coming years. There are several factors driving the increased adoption of tomosynthesis in breast cancer screening. First, tomosynthesis has been shown to be more sensitive than 2D mammography in detecting breast cancer, particularly in dense breasts.Dense breasts are a risk factor for breast cancer, and they can make it difficult to see tumors on 2D mammograms. Tomosynthesis can overcome this challenge by creating 3D images of the breast, which allows radiologists to see tumors that may be hidden on 2D mammograms. Second, tomosynthesis is more specific than 2D mammography, meaning that it is less likely to produce false positives. False positives can lead to unnecessary biopsies and anxiety for patients.Tomosynthesis can help to reduce the number of false positives by providing radiologists with more information about the breast tissue. Third, tomosynthesis is relatively quick and easy to perform. It takes only a few minutes to complete a tomosynthesis exam, and it is well-tolerated by patients. This makes tomosynthesis a convenient and accessible option for breast cancer screening. The increasing adoption of tomosynthesis in breast cancer screening is a positive development, as it is likely to lead to earlier detection and better outcomes for patients.Tomosynthesis is a valuable tool in the fight against breast cancer, and it is expected to play an increasingly important role in the years to come.

Technological Advancements in Tomosynthesis Systems

The GN Global Tomosynthesis Industry continues to make substantial technological advances as manufacturers develop more sophisticated and user-friendly systems. The technological advances are based on improving image quality, reducing radiation dose and improving workflow efficiency. The technology advancements continue to improve the quality of images that can be diagnosed using tomosynthesis. Currently, one of the significant technological advances in the tomosynthesis systems is the development of iterative reconstruction algorithms.The algorithms use sophisticated mathematical techniques to reconstruct images from raw data. This method reduces the amount of noise in the resultant images while at the same time improving the quality of images. The algorithms have been proven to improve the small lesions and reduce the handling of cancers that are being missed. The technological advancement also includes the development of low doses tomosynthesis systems. The systems use advanced X-ray detectors and imaging techniques to achieve low radiation doses to the patients.The systems are specifically desirable for tomosynthesis for the diagnosis of breast cancer. The development of low-dose systems increases patients' acceptance of the technology in cancer diagnosis, as the risks of patients developing cancer from radiation can be reduced without reducing the image quality. The technology advancements also include systems being developed to improve workflow efficiency. The systems come complete with automated image acquisition and processing tools, which reduces the time and the work required to perform tomosynthesis exams. The improved workflow efficiency also leads to reduced aggregate costs due to the high patient throughput.

Rising Prevalence of Breast Cancer

The driver of the Tomosynthesis Market Industry is the increasing prevalence of breast cancer in the world. Breast cancer is one of the most common cancers among women, and its prevalence seems to be increasing in many parts of the world. Many aspects explain such a fact, including an increased life expectancy in the majority of the world, changes in lifestyles, and human behavior and environmental factors. The increase in breast cancer is also leading to an increase in the demand for efficient screening and diagnostics.Tomosynthesis is a good tool in the fight against breast cancer in that it helps detect breast cancer early on in the disease course, which is when cancer is the most easily treatable. In addition to cancer screening, tomosynthesis is a helpful tool in the diagnostics of breast cancer in that, for example, it can help to establish the exact size of the tumor. One can expect that the increasing prevalence of breast cancer will be a long-term trend in the upcoming years.Therefore, tomosynthesis might be a good tool to ensure that more women have early access to the best possible breast cancer care.

Tomosynthesis Market Segment Insights

Tomosynthesis Market Application Type Insights  

Application Type Segment Insights and Overview The Tomosynthesis Market is segmented by application type into breast cancer, lung cancer, osteoporosis, corneal disease, and kidney stone. The breast cancer segment held the largest market share in 2023 and is expected to continue dominating the market over the forecast period. This is attributed to the increasing prevalence of breast cancer coupled with the increasing adoption of tomosynthesis in breast cancer screening. The lung cancer segment is expected to have considerable growth over the forecast period due to the increasing incidence of lung cancer and the increasing utilization of tomosynthesis in lung cancer diagnosis and staging.The osteoporosis segment is expected to have consistent growth over the forecast period, and this is attributed to the increasing prevalence of osteoporosis and the increasing adoption of tomosynthesis in osteoporosis diagnosis. The corneal disease segment is expected to have moderate growth over the forecast period, and the growth is driven by the increasing prevalence of corneal diseases and the increasing utilization of tomosynthesis in the diagnosis and treatment of corneal disease. The utilization of the technology in kidney stone applications is expected to have slow growth over the forecast period due to the increasing incidence of kidney stones and the increasing utilization of tomosynthesis in kidney stone diagnosis and treatment planning.The growth is attributed to the increasing prevalence of various types of diseases, the increasing utilization of tomosynthesis in disease diagnosis and surgical planning, and the advancements in the tomosynthesis systems.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Tomosynthesis Market End-Use Setting Insights  

The Tomosynthesis Market segmentation by End-Use Setting includes Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, and Research Institutions. Hospitals held the dominant market share in 2023 owing to the high prevalence of chronic diseases, increasing patient population, and technological advancements. The rising number of specialized hospitals and the integration of advanced tomosynthesis systems to enhance diagnostic accuracy further contribute to market growth. Diagnostic Centers are expected to witness significant growth due to the increasing demand for specialized imaging services and the growing preference for outpatient settings.Ambulatory Surgical Centers are gaining popularity for tomosynthesis procedures as they offer convenience, cost-effectiveness, and shorter recovery times, driving market expansion. Research Institutions play a crucial role in tomosynthesis development, conducting clinical trials, and advancing research on new applications, thereby fueling market growth.

Tomosynthesis Market Technology Insights  

The market is driven by the increasing adoption of tomosynthesis in breast cancer screening and diagnosis, as well as the growing demand for minimally invasive procedures. The technology segment of the tomosynthesis market is segmented into digital tomosynthesis and digital breast tomosynthesis. Digital tomosynthesis is a type of tomosynthesis that uses digital detectors to capture images of the breast. Digital breast tomosynthesis (DBT) is a type of digital tomosynthesis that is specifically designed for breast imaging. DBT is more sensitive than traditional mammography in detecting breast cancer, and it can also help to reduce the number of false positives.The digital tomosynthesis segment is expected to grow at a faster rate than the digital breast tomosynthesis segment over the forecast period. This is due to the increasing adoption of digital tomosynthesis in breast cancer screening and diagnosis. Digital tomosynthesis is more affordable than DBT, and it can be used in a wider range of settings.

Tomosynthesis Market Component Insights  

The Component segment of the Tomosynthesis Market is categorized into X-ray Tubes, detectors, Image Processing Software, Accessories and Consumables. Among these, the X-ray Tube segment held the largest market share in 2023, owing to its high demand in various medical applications. The Detector segment is anticipated to exhibit the highest CAGR during the forecast period, attributed to the increasing adoption of advanced imaging techniques and the growing need for accurate and efficient medical diagnosis. The Tomosynthesis Market revenue is expected to reach USD 15.5 billion by 2032, growing at a CAGR of 10.37% during the forecast period.The market growth is driven by factors such as the rising prevalence of chronic diseases, increasing demand for early disease detection, and technological advancements in the healthcare industry

Tomosynthesis Market Regional Insights  

The regional segmentation of the Tomosynthesis Market offers valuable insights into the market's geographical distribution and growth patterns. North America is currently the dominant region, accounting for the largest share of the market in 2023 and is projected to maintain its position in the coming years. The region's advanced healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of cancer drive growth in this region. Europe follows North America in terms of market size, with a significant contribution from countries such as Germany, France, and the United Kingdom.The growing adoption of tomosynthesis systems for breast cancer screening and diagnosis, as well as increasing awareness of the technology, is fueling the market growth in this region. Asia-Pacific (APAC) is anticipated to witness the fastest growth rate during the forecast period. The rising incidence of cancer, coupled with increasing healthcare expenditure and government initiatives to improve healthcare access, is driving the demand for tomosynthesis systems in this region. South America, the Middle East, and Africa (MEA) are expected to experience steady growth in the coming years due to increasing investments in healthcare infrastructure and growing awareness of the benefits of tomosynthesis.The Tomosynthesis Market is expected to witness significant growth, driven by factors such as increasing cancer prevalence, technological advancements, and rising demand for accurate and efficient diagnostic tools.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Tomosynthesis Market Key Players And Competitive Insights

The competitive landscape of the Tomosynthesis Market is highly dynamic, with several key players competing for market share. Leading Tomosynthesis Market players have established their presence through partnerships and collaborations, technology development, and distribution networks. The contenders in the Tomosynthesis Market include Hologic, Inc., Siemens Healthineers AG, Canon Medical Systems Corporation, GE Healthcare, and Fujifilm Holdings Corporation.Major players are investing in the development of the Tomosynthesis Industry. They emphasize technological advancements and product innovation as ongoing trends will compete for market share. As the competitive landscape further evolves, the market is poised to become more competitive with new contenders and technologies.

Dynamic business environments present both opportunities and threats in the Tomosynthesis Market

Hologic, Inc., a US-based company, is a leading player in the Tomosynthesis Market. Its success in the market can be attributed to its innovative 3D mammography systems. Over the years, the company's Genius 3D Mammography exam has been used by healthcare providers for breast cancer detection. Hologic's robust brand and distribution networks further cement its stand in the market. The company also increased its expenditure for developing new products, giving it an edge over the other contenders. Some of Hologic, Inc.'s products include the 3D Mammography screen and The Affirm-prone biopsy system.GE Healthcare is a key player in the Tomosynthesis Market that uses medical imaging technology to offer other services. SenoClaire Breast Tomosynthesis System is the company's premier product, well known for its super resolution images and advanced processing algorithms. GE Healthcare has also branded its presence in emerging markets, a factor that has gained the company an added advantage. It is known for its ongoing innovation and commitment to customer satisfaction.

Key Companies in the Tomosynthesis Market Include

• Sedecal Orthopaedic SA


• Toshiba Medical Systems Corporation


• Canon Medical Systems Corporation


• Philips Healthcare


• Planmed Oy


• AB Vista


• Sysmex Corporation


• Fujifilm Holdings Corporation


• GenMark Diagnostics, Inc.


• Siemens Healthineers


• PerkinElmer, Inc.


• Agilent Technologies, Inc.


• GE Healthcare


• Hologic


• Hitachi Medical Corporation

Tomosynthesis Market Industry Developments

The Tomosynthesis Market size was valued at USD 5.18 billion in 2023 and is projected to expand at a CAGR of 10.37% from 2024 to 2032, reaching USD 15.5 billion by the end of the forecast period. The market growth is primarily driven by the increasing prevalence of breast cancer, technological advancements in tomosynthesis systems, and the growing demand for minimally invasive diagnostic procedures. Recent news developments include the launch of new tomosynthesis systems with enhanced imaging capabilities by major players such as Siemens Healthineers and GE Healthcare. Additionally, government initiatives and reimbursement policies aimed at improving breast cancer screening rates are expected to contribute to the market growth.

Tomosynthesis Market Segmentation Insights

Tomosynthesis Market Application Type Outlook

• Breast Cancer


• Lung Cancer


• Osteoporosis


• Corneal Disease


• Kidney Stone

Tomosynthesis Market End-Use Setting Outlook

• Hospitals


• Diagnostic Centers


• Ambulatory Surgical Centers


• Research Institutions

Tomosynthesis Market Technology Outlook

• Digital Tomosynthesis


• Digital Breast Tomosynthesis

Tomosynthesis Market Component Outlook

• X-ray Tube


• Detector


• Image Processing Software


• Accessories and Consumables

Tomosynthesis Market Regional Outlook

• North America


• Europe


• South America


• Asia-Pacific


• Middle East and Africa